18 results
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
, without limitation: (i) all expenses incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs … or the securities laws of any other country; (vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Placement Agents
8-K
EX-10.11
ATXI
Avenue Therapeutics Inc
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
or termination of this Agreement.
Section 5. Registration Expenses
The Company shall pay all expenses incident to the performance by the Company of its
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including … Proceedings. All corporate proceedings and other legal matters incident to the authorization, form and validity of each of this Agreement
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but not limited … Proceedings. All corporate proceedings and other legal matters incident to the authorization, form and validity of each of this Agreement, the Securities
10-12G
EX-3.3
swl3v0j y2gc2
30 Dec 15
Registration of securities
12:00am
10-12G
EX-3.2
8xhore2bso5vtj12bt
12 Jan 17
Registration of securities
12:00am
8-K
EX-3.1
fcvqcphcdv6en8hukzl
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
424B3
7yx19an k2puv45
4 May 23
Prospectus supplement
4:30pm
8-K
EX-10.1
qswx9tzfca08h4
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.2
icm9kpn1f7fsuzi8a
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-1.1
tlo0btfd4h
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
PREM14A
z55ub8b1tm76cusrcx1f
11 Dec 18
Preliminary proxy related to merger
5:23pm
DEFM14A
2dav0zx
21 Dec 18
Proxy related to merger
12:23pm
- Prev
- 1
- Next